These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 31828062

  • 21. Similarity and difference between palmoplantar pustulosis and pustular psoriasis.
    Yamamoto T.
    J Dermatol; 2021 Jun; 48(6):750-760. PubMed ID: 33650702
    [Abstract] [Full Text] [Related]

  • 22. Nail lesions in palmoplantar pustulosis and pustulotic arthro-osteitis impairs patients' quality of life: Suggesting new assessment tool of PPP nail lesions.
    Masuda-Kuroki K, Kawakami H, Abe N, Mori M, Tobita R, Fukushi R, Hiruma J, Takeda Y, Okubo Y.
    J Dermatol Sci; 2022 Apr; 106(1):29-36. PubMed ID: 35307234
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Identification of nail features associated with psoriasis severity.
    Choi JW, Kim BR, Seo E, Youn SW.
    J Dermatol; 2017 Feb; 44(2):147-153. PubMed ID: 27599783
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Dermoscopic Features of Nail Psoriasis: Revisited.
    Yorulmaz A, Aksoy GG.
    Skin Appendage Disord; 2022 Sep; 8(5):389-398. PubMed ID: 36161089
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Economic Burden of Palmoplantar Pustulosis in Sweden: A Population-based Register Study.
    Löfvendahl S, Norlin JM, Schmitt-Egenolf M.
    Acta Derm Venereol; 2023 Jan 09; 103():adv00843. PubMed ID: 36621923
    [Abstract] [Full Text] [Related]

  • 29. Clinical and epidemiological comparison of patients affected by palmoplantar plaque psoriasis and palmoplantar pustulosis: a case series study.
    Brunasso AM, Puntoni M, Aberer W, Delfino C, Fancelli L, Massone C.
    Br J Dermatol; 2013 Jun 09; 168(6):1243-51. PubMed ID: 23301847
    [Abstract] [Full Text] [Related]

  • 30. Dystrophic psoriatic fingernails treated with 1% 5-fluorouracil in a nail penetration-enhancing vehicle: a double-blind study.
    de Jong EM, Menke HE, van Praag MC, van De Kerkhof PC.
    Dermatology; 1999 Jun 09; 199(4):313-8. PubMed ID: 10640840
    [Abstract] [Full Text] [Related]

  • 31. Histopathological Findings in Nail Clippings With Periodic Acid-Schiff-Positive Fungi.
    Mishlab S, Avitan-Hersh E, Bergman R.
    Am J Dermatopathol; 2021 May 01; 43(5):338-341. PubMed ID: 32956097
    [Abstract] [Full Text] [Related]

  • 32. Single Blinded Left-to-Right Comparison Study of Excimer Laser Versus Pulsed Dye Laser for the Treatment of Nail Psoriasis.
    Al-Mutairi N, Noor T, Al-Haddad A.
    Dermatol Ther (Heidelb); 2014 Dec 01; 4(2):197-205. PubMed ID: 24990703
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Coexistence of onychomycosis in psoriatic nails: a descriptive study.
    Natarajan V, Nath AK, Thappa DM, Singh R, Verma SK.
    Indian J Dermatol Venereol Leprol; 2010 Dec 01; 76(6):723. PubMed ID: 21079333
    [Abstract] [Full Text] [Related]

  • 35. Assessment of nail unit structures by ultrasound in patients with psoriatic arthritis and their correlations with disease activity indices: a case-control study.
    Mondal S, Dutta S, Lahiri D, Sinha D, Sircar G, Mandal AK, Kejriwal M, Ghosh A.
    Rheumatol Int; 2018 Nov 01; 38(11):2087-2093. PubMed ID: 30225658
    [Abstract] [Full Text] [Related]

  • 36. Subclinical enthesopathy of extensor digitorum tendon is highly prevalent and associated with clinical and ultrasound alterations of the adjacent fingernails in patients with psoriatic disease.
    Moya Alvarado P, Roé Crespo E, Muñoz-Garza FZ, López-Ferrer A, Laiz Alonso A, Vilarrassa Rull E, Casademont I Pou J, Puig Sanz L.
    J Eur Acad Dermatol Venereol; 2018 Oct 01; 32(10):1728-1736. PubMed ID: 29706002
    [Abstract] [Full Text] [Related]

  • 37. Sustained High Efficacy and Favorable Safety Over Five Years in Patients With Burdensome Psoriasis (UNCOVER-1/UNCOVER-2).
    Papp KA, Gerdes S, Leonardi CL, Elmaraghy H, See K, McKean-Matthews M, Konicek BW, Crane HM, Eastman W.
    J Drugs Dermatol; 2021 Aug 01; 20(8):880-887. PubMed ID: 34397207
    [Abstract] [Full Text] [Related]

  • 38. Ixekizumab and Ustekinumab Efficacy in Nail Psoriasis in Patients with Moderate-to-Severe Psoriasis: 52-Week Results from a Phase 3, Head-to-Head Study (IXORA-S).
    Wasel N, Thaçi D, French LE, Conrad C, Dutronc Y, Gallo G, Berggren L, Lacour JP.
    Dermatol Ther (Heidelb); 2020 Aug 01; 10(4):663-670. PubMed ID: 32415575
    [Abstract] [Full Text] [Related]

  • 39. X-ray fluorescence measurements of arsenic micro-distribution in human nail clippings using synchrotron radiation.
    Gherase MR, Desouza ED, Farquharson MJ, McNeill FE, Kim CY, Fleming DE.
    Physiol Meas; 2013 Sep 01; 34(9):1163-77. PubMed ID: 24137704
    [Abstract] [Full Text] [Related]

  • 40. Psoriatic nails: a prospective clinical study.
    Salomon J, Szepietowski JC, Proniewicz A.
    J Cutan Med Surg; 2003 Sep 01; 7(4):317-21. PubMed ID: 12879333
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.